Your dreaming... Shinn has a "HOMERUN" drug, and the big pharmas would shelf this drug, and the cost thru phase four is in the neighborhood cost of 400 million to approve. Shinn doesn't have that kind of backing.That's why I believe Africa was the target, or the treatment facility in the Bahama's.
Market Data 
Markets 
AI
